TECN.SW
TECN.SW
CH0012100191
TECAN GROUP AG N
Loading chart...

Company Profile

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Related stocks

YPSN.SW
YPSN.SW • Switzerland
YPSOMED HLDG
362.2 CHF
5.74B USD 1Y +6.9%
SKAN.SW
SKAN.SW • Switzerland
SKAN N
70.7 CHF
1.92B USD 1Y +22.5%
OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
AFX.DE
AFX.DE • Germany
Carl Zeiss Meditec AG I
32.42 EUR
3.18B USD 1Y -30.7%
FIE.DE
FIE.DE • Germany
Fielmann Group AG I
37.35 EUR
3.51B USD 1Y -25.6%
STVN
STVN • Italy
Stevanato Group S.p.A.
19.4 USD
5.3B USD 1Y -21.8%
CTEC.L
CTEC.L • United Kingdom
CONVATEC GROUP PLC ORD 10P
220 GBp
5.58B USD 1Y -11.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.3% p.a.
Max Drawdown (5Y)
-80.4%
Sharpe Ratio (5Y)
-0.44
Beta Factor
1.01
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -80.7% in the extended horizon.
ende